Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

Published:2013-10-01 Issue:1 Volume:164 Page:39-52
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Collins Graham P.¹,Parker Anne N.²,Pocock Christopher³,Kayani Irfan⁴,Sureda Anna⁵,Illidge Tim⁶,Ardeshna Kirit⁷,Linch David C.⁷⁸,Peggs Karl S.⁷⁸,

Affiliation:

1. Department of Haematology; Oxford Cancer and Haematology Centre; Churchill Hospital; Oxford UK

2. HPC Transplant Programme; Beatson West of Scotland Cancer Centre; Glasgow UK

3. Department of Haematology; East Kent Hospitals NHS Trust; Canterbury UK

4. Department of Nuclear Medicine; University College London Hospitals NHS Trust; London UK

5. Department of Haematology; Addenbrookes Hospital; Cambridge University; Cambridge UK

6. Institute of Cancer Sciences; University of Manchester; The Christie Hospital; Manchester UK

7. Department of Haematology; University College London Hospitals NHS Trust; London UK

8. Department of Haematology; UCL Cancer Institute; University College London; London UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12582/fullpdf

Reference88 articles.

1. Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience;Anderlini;Haematologica,2008

2. ESHAP is an active regimen for relapsing Hodgkin's disease;Aparicio;Annals of Oncology,1999

3. Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group;Baetz;Annals of Oncology,2003

4. Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804;Bartlett;Annals of Oncology,2007

5. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma;Benekli;Bone Marrow Transplantation,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low fixed dose pembrolizumab with gemcitabine, vinorelbine, liposomal doxorubicin (Pembro100 -GVD) as an effective salvage regimen in relapsed refractory classical hodgkin’s lymphoma and primary mediastinal B cell lymphoma;Annals of Hematology;2023-09-23

2. Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma;Frontiers in Oncology;2023-06-27

3. Stem Cell Transplant for Hodgkin Lymphoma;Basics of Hematopoietic Stem Cell Transplant;2023

4. Milestones in Hematology and Oncology: From Fatal to Curable Disease;PRILOZI;2022-07-01

5. Brentuximab vedotin in adult patients with HL CD30+ at high risk of relapse or progression following ASCT: a cost-analysis in Italy;AboutOpen;2021-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3